title: Skin blood flow in patients with stage 5 chronic kidney disease on hemodialysis.
abstract: We have shown previously that skin perfusion is reduced in patients with diabetes mellitus (DM). Patients with diabetes and with chronic kidney disease (CKD) stage 5 were having advanced microangiopathy. In this cross-sectional study, we measured skin blood flow in DM and non-DM patients on dialysis to assess whether any differences exist in skin perfusion in those 2 groups of patients. A total of 25 patients with DM (aged 59.9 +/- 2.2 years) and 24 patients with non-DM CKD stage 5 (44.6 +/- 2.9 years) on hemodialysis (HD) were studied. Ten healthy subjects (37 +/- 4.3 years) were used as a control group. Skin blood flow (SBF) was measured using Vasamedic Model 403B laser Doppler device (Vasamedics Inc., St. Paul, MN) in a standardized way at the plantar and dorsal surface of the finger and toe and at the pretibial surface of the leg at 2 different local skin temperatures of 35 degrees C and 44 degrees C. Laboratory biochemical data were collected at the time of SBF study. The SBF measured at 35 degrees C was lower in the patients with DM on dialysis as compared with healthy subjects and non-DM dialysis patients. The SBF response to the increase in temperature of the probe to 44 degrees C was 70% to 80% lower in DM patients as compared with healthy subjects and non-DM patients. However, non-DM subjects who displayed SBF similar to control subjects at 35 degrees C, had impaired response in SBF at 44 degrees C as well. Patients with lower serum albumin exhibited lower SBF even after adjustment for age. SBF is impaired in patients with stage 5 CKD on HD, particularly in those with DM as a cause of CKD. SBF negatively correlated with age and albumin (nutritional status) in DM and non-DM patients with stage 5 CKD on HD. Measurement of SBF can be useful in the evaluation of vasculopathy in CKD population and can potentially be used for assessment of vascular response during specific clinical intervention.
authors.affiliation: Department of Dermatology, University of Southern California, Keck School of Medicine, Los Angeles, California, USA.
authors.forename: Binh
authors.initials: B
authors.lastname: Ngo
authors.forename: Christine
authors.initials: C
authors.lastname: Rongey
authors.forename: Bryan
authors.initials: B
authors.lastname: Hiscox
authors.forename: Marc
authors.initials: M
authors.lastname: Rendell
authors.forename: David
authors.initials: D
authors.lastname: Woodley
authors.forename: Miroslaw
authors.initials: M
authors.lastname: Smogorzewski
mesh_terms: D000328:Adult; D001783:Blood Flow Velocity; D003430:Cross-Sectional Studies; D048909:Diabetes Complications / Q000503:physiopathology; D003925:Diabetic Angiopathies / Q000503:physiopathology; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000503:physiopathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D012867:Skin / Q000098:blood supply*; D012871:Skin Diseases / Q000150:complications / Q000503:physiopathology